2025 MaTOS Breast | Bispecific/Biparatopic Antibodies in Breast Cancer (Zanidatimab, PM8002, etc)

2025 MaTOS Breast | Bispecific/Biparatopic Antibodies in Breast Cancer (Zanidatimab, PM8002, etc)

Overview

NA

Target Audience

NA

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Paula Pohlmann, MD, PhD

Date of Release

May 14th, 2025